Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Finished Goods (2017 - 2025)

Historic Finished Goods for Dexcom (DXCM) over the last 13 years, with Q4 2025 value amounting to $266.5 million.

  • Dexcom's Finished Goods rose 4220.92% to $266.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $266.5 million, marking a year-over-year increase of 4220.92%. This contributed to the annual value of $266.5 million for FY2025, which is 4220.92% up from last year.
  • According to the latest figures from Q4 2025, Dexcom's Finished Goods is $266.5 million, which was up 4220.92% from $259.5 million recorded in Q3 2025.
  • Dexcom's 5-year Finished Goods high stood at $266.5 million for Q4 2025, and its period low was $107.9 million during Q1 2025.
  • Its 5-year average for Finished Goods is $187.5 million, with a median of $190.5 million in 2023.
  • As far as peak fluctuations go, Dexcom's Finished Goods surged by 20986.62% in 2021, and later crashed by 5468.29% in 2025.
  • Dexcom's Finished Goods (Quarter) stood at $195.9 million in 2021, then tumbled by 33.38% to $130.5 million in 2022, then soared by 61.0% to $210.1 million in 2023, then dropped by 10.8% to $187.4 million in 2024, then surged by 42.21% to $266.5 million in 2025.
  • Its last three reported values are $266.5 million in Q4 2025, $259.5 million for Q3 2025, and $130.6 million during Q2 2025.